$218.56
6.012.83%
Últ. Act.: Aug 19, 1:15 PM
Biogen Inc
BIIBNASDAQ
Biogen Earnings & Forecasts
Biogen (BIIB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Biogen Guidance
Biogen (BIIB) emitió su última guía sobre julio 29, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $15.85 - $16.85, en comparación con una estimación de consenso de EPS de $13.45.
En comparación con la previsión anterior, Biogen elevado redujo su previsión de BPA desde un rango anterior de $15.25 - $16.25.
Biogen ha emitido 16 actualizaciones de orientación entre el octubre 25, 2022 y el julio 29, 2026. During this period, the company raised its outlook 6 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.35 | $2.95 | $1.62 | $3.89 |
| Actual | $3.60 | $3.57 | $1.99 | $4.81 |
| Surprise | +53.2% | +21.0% | +22.8% | +23.6% |
| Revenue | ||||
| Estimate | $2.42B | $2.25B | $2.21B | $2.34B |
| Actual | $2.74B | $2.48B | $2.28B | $2.53B |
| Surprise | +13.0% | +10.2% | +3.29% | +8.22% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.20 | $3.30 | $3.78 | $4.65 |
| Revenue | ||||
| Consensus | $2.63B | $2.60B | — | — |